Stockwinners Market Radar for July 24, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:11 EDT Cathie Wood's ARK Investment buys 33.1K shares of Tesla today

20:09 EDT Cathie Wood's ARK Investment buys 392.5K shares of 10x Genomics today

19:50 EDT EzFill Holdings Inc trading halted, news pending

19:28 EDT Riot says Ontario Capital Markets Tribunal terminates Bitfarm poison pill - Riot Platforms (RIOT) "announced that it was successful in its application to the Ontario Capital Markets Tribunal to cease trade the June 10, 2024 shareholder rights plan implemented by the Board of Directors of Bitfarms Ltd. (BITF). The cease trade order terminates Bitfarms' Poison Pill - which contemplated a 15% trigger - effective immediately." Jason Les, Riot CEO, says: "This ruling from the Tribunal in favor of Riot's application is a win for all Bitfarms shareholders. The adoption of the off-market Poison Pill is yet another example of the broken corporate governance that plagues Bitfarms and of the ongoing attempts by the Bitfarms directors to entrench themselves. We appreciate that the Tribunal acted quickly and decisively to remove the Poison Pill. We continue to believe that our three director nominees - John Delaney, Amy Freedman and Ralph Goehring - must be elected to the Bitfarms Board at the 2024 Special Meeting of Shareholders scheduled for October 29, 2024 in order to repair Bitfarms' poor corporate governance. These Nominees are fully independent of Riot and Bitfarms, are highly qualified and will bring much-needed fresh perspectives into the boardroom. We look forward to communicating further with shareholders in the coming weeks and months."

18:15 EDT Everspin announces new strategic contract with QuickLogic - Everspin Technologies (MRAM) announced a new strategic contract with QuickLogic Corporation (QUIK). "Everspin is pleased to continue its collaboration with its partners QuickLogic and Honeywell to integrate MRAM directly into the FPGA product to support the DoD," said Sanjeev Aggarwal, President Technologies and CEO of Everspin Technologies. "This project builds upon over 12 years of Everspin's experience in delivering MRAM IP for strategic radiation hardened and space applications." Under the contract, Everspin will provide its innovative AgILYST MRAM technology, logic design, and back end of line manufacturing services to advance the development and demonstration of a Strategic Radiation Hardened high-reliability Field Programmable Gate Array technology. This initiative supports both current and future Department of Defense strategic and space system requirements. The contract with Everspin Technologies is valued at approximately $1.8M.

17:28 EDT Ford says 'absolutely' a different company compared to three years ago - Says pace of change is intensifying. Says getting more "resourceful and scrappy" in terms of turning the company around. Sees 2H24 similar to 1H24. Says smaller EVs are the right choice for high volume production. Says CO2 credits likely needed to meet regulations. Says targeting $1B in revenue from software sales in 2025. Comments taken from Q2 earnings conference call.

17:05 EDT SLB expects to close acquisition of ChampionX in 4Q24 or 1Q25

16:53 EDT ServiceNow raises FY24 subscription revenue view to $10.575B-$10.585B - Prior guidance was $10.56B - $10.575B.

16:48 EDT Home Federal Bancorp raises quarterly dividend to 13c per share from 12.5c - The dividend is payable on August 19, 2024, to the shareholders of record at the close of business on August 5, 2024.

16:42 EDT Alerus Financial reports Q2 net interest margin 2.39% vs. 2.30% in Q1 - The company states: "Net interest margin was 2.39% in the second quarter of 2024, compared to 2.30% in the first quarter of 2024. Adjusted net interest margin increased 13 basis points from 2.44% in the first quarter of 2024 to 2.57% in the second quarter of 2024. Net interest income was $24.0 million in the second quarter of 2024, an increase of 8.0% from $22.2 million in the first quarter of 2024. Total assets under administration/management at June 30, 2024 were $43.6 billion, a 1.9% increase from March 31, 2024."

16:34 EDT KKR acquires Marmic Fire & Safety; terms not stated - KKR "announced that investment funds managed by KKR have acquired Marmic Fire & Safety, a leading provider of regulation-mandated fire equipment inspection, testing and maintenance services, from HGGC. Financial terms were not disclosed. Marmic specializes in the inspection, testing, and maintenance of fire protection equipment for more than 56,000 customers across the commercial, industrial, multi-family, education, government, and healthcare end markets in the U.S. Since its founding in 1951, Marmic has provided services that are critical to keeping its customers safe and helping them adhere to local and national fire codes and regulations."

16:32 EDT Churchill Downs announces $80M-$90M renovation to racetrack grandstand - Churchill Downs announced an $80M-$90M renovation to the existing grandstand at Churchill Downs Racetrack that will update ticketed seating options while improving and adding to the amenities available for all guests in the grandstand area. Construction on the Grandstand Club and Pavilion is scheduled to begin in August with completion planned in time for the 151st Kentucky Derby in May 2025. The renovation of the Grandstand Club will transform existing outdoor aluminum bleachers into a combination of 8,300 new seating varieties. Updated seating options will include covered and uncovered stadium-style seats as well as rail boxes along the dirt track's outer rail that will offer a "trackside" seating experience. First-floor amenities for the Grandstand Club will include new and upgraded permanent concessions, bars and wagering windows. The project will also improve and add amenities for 2,800 guests in the existing third floor box seats under the Starting Gate Suites. The Grandstand Pavilion will create a more upscale social environment by converting the existing second-floor amenity area into a covered outdoor garden environment with new concessions, bars and wagering windows. Expansion to the second floor will create additional space for overall guest circulation and add an outdoor balcony for added dining seats. A new stately entrance to the Grandstand Pavilion will unify the surrounding exterior architecture.

16:28 EDT PayPal appoints Enrique Lores as new Independent Board Chair - PayPal Holdings (PYPL) announced that Enrique Lores has been appointed the new Independent Chair of its Board of Directors. He succeeds John Donahoe, who is retiring from the PayPal Board after serving as Board Chair since 2015. Lores, President and CEO of HP Inc. (HPQ), has served on the Board since June 2021.

16:26 EDT NBA enters into long-term arrangement with Amazon

16:25 EDT BioMarin announces FDA approval of sBLA for BRINEURA - BioMarin Pharmaceutical announced that the U.S. FDA has approved the company's supplemental Biologics License Application for BRINEURA to slow the loss of ambulation in children of all ages with neuronal ceroid lipofuscinosis type 2, also known as tripeptidyl peptidase 1 deficiency. Previously, BRINEURA was indicated in symptomatic children 3 years of age and older with late infantile CLN2 disease. This expanded indication now includes children of all ages with CLN2 disease, regardless of whether they are symptomatic or presymptomatic.

16:22 EDT Impinj expands leadership team - Impinj announced executive promotions and an expanded executive leadership team that position the company for continued growth. Gahan Richardson was promoted to executive vice president, focused on executing Impinj's strategy to win the RAIN RFID market opportunity. Richardson will join the executive leadership team and oversee the company's product roadmap and market and ecosystem development. Impinj also added Alberto Pesavento, chief technology officer and a 23-year Impinj veteran, to the executive leadership team and promoted Christina Balam, already a member of the executive team, to senior vice president of human resources.

16:20 EDT Bank of America raises dividend 8%, announces $25B share repurchase plan - Bank of America announced the Board of Directors declared a regular quarterly cash dividend on Bank of America common stock of 26c per share, up 2c from the prior quarter. The dividend is payable on September 27 shareholders of record as of September 6. The Board also authorized a new $25B common stock repurchase program, effective August 1, 2024, to replace the company's current program, which will expire on that date. As of June 30, 2024, the current program had approximately $6.7 billion in common stock repurchases remaining. Today's authorization will continue to provide additional capital return flexibility going forward, in line with the company's commitment to return to shareholders excess capital that is not needed to support economic growth, deliver for customers and communities, invest in the future and sustain strength and stability through the economic cycle.

16:16 EDT IBM up 5% after Q2 earnings beat - Shares of IBM are up $8.48, or 5%, to $192.50 in after-hours trading.

16:14 EDT ServiceNow sees Q3 subscription revenue up 20.5% at $2.66B-$2.665B

16:13 EDT Republic Services increases quarterly dividend 4.5% to 58c per share - Republic Services approved a 4.5% increase in the quarterly dividend. The quarterly dividend of 58c per share for shareholders of record on October 2, will be paid on October 15.

16:11 EDT Chipotle sees FY24 comparable restaurant sales growth mid to high single digits - For 2024, management is anticipating the following: Full year comparable restaurant sales growth in the mid to high-single digit range; 285 to 315 new restaurant openings with over 80% having a Chipotlane; An estimated underlying effective full year tax rate between 25% and 27% before discrete items.

16:10 EDT Ford on course for 'solid' FY24 operating performance

16:08 EDT Kemper reports Q2 preliminary adjusted net income of $85M-$95M

16:06 EDT Koru Medical names Christopher Pazdan as new COO - KORU Medical announced the promotion of Christopher Pazdan, to Chief Operating Officer, effective July 18, 2024. Mr. Pazdan has been with the organization since 2021, and last served as the Company's Senior Vice President of Operations overseeing Quality, Regulatory, Operations, Supply Chain and Project Management. In his role as COO, Chris will also oversee the Research and Development organization and be responsible for the Company's product development pipeline and innovation efforts.

16:05 EDT Knight-Swift reports Q2 Truckload operating ratio 97.2% vs. 91.8% last year - Reports Q2 Less-Than-Truckload operating ratio 85.9% vs. 85.1% last year

16:01 EDT Meta removes 63,000 Instagram accounts in Nigeria over 'sextortion' scams - Meta said in a blog post that it has removed around 63,000 Instagram accounts in Nigeria attempting to target people with financial sextortion scams, including a coordinated network of around 2,500 accounts. It said it has also removed a set of Facebook accounts, Pages and Groups "run by Yahoo Boys - banned under our Dangerous Organizations and Individuals policy - that were attempting to organize, recruit and train new scammers." Meta noted that "While our investigation showed that the majority of these scammers' attempts were unsuccessful and mostly targeted adults, we did see some also attempt to target minors, and we've reported those accounts to the National Center for Missing and Exploited Children." Finally, the company said that it removed around 7,200 assets, including 1,300 Facebook accounts, 200 Facebook Pages and 5,700 Facebook Groups, also based in Nigeria, that were providing tips for conducting scams. Reference Link

15:16 EDT Scotiabank cuts prime lending rate to 6.7% from 6.95% - Scotiabank announced that it is decreasing its Canadian dollar prime lending rate to 6.7% from 6.95%, effective July 25, 2024.

15:03 EDT Apple Maps on the web launches in beta - Apple Maps on the web is available in public beta, allowing users around the world to access Maps directly from their browser. "Now, users can get driving and walking directions; find great places and useful information including photos, hours, ratings, and reviews; take actions like ordering food directly from the Maps place card; and browse curated Guides to discover places to eat, shop, and explore in cities around the world. Additional features, including Look Around, will be available in the coming months. All developers, including those using MapKit JS, can also link out to Maps on the web, so their users can get driving directions, see detailed place information, and more. Maps on the web is currently available in English, and is compatible with Safari and Chrome on Mac and iPad, as well as Chrome and Edge on Windows PCs. Support for additional languages, browsers, and platforms will be expanded over time," the company stated. Reference Link

14:41 EDT Progressive CFO Sauerland sells 22,708 common shares - In a regulatory filing, Progressive CFO John Sauerland disclosed the sale of 22,708 common shares of the company on July 22 at a price of $214.01 per share.

14:05 EDT Microsoft introduces new generative search experience on Bing - Microsoft said in a blog post, "After introducing LLM-powered chat answers on Bing in February of last year, we've been hard at work on the ongoing revolution of search. Bing continues to be trusted by hundreds of millions of users to find information, get answers to questions, and explore their curiosity. Today, we're excited to share an early view of our new generative search experience which is currently shipping to a small percentage of user queries. By combining the power of generative AI and large language models (LLMs) with the search results page, Bing's generative search creates a bespoke and dynamic response to a user's query...This is another important step in evolving the search experience on Bing and we're eager to get feedback throughout this journey. We are slowly rolling this out and will take our time, garner feedback, test and learn, and work to create a great experience before making this more broadly available." Reference Link

13:10 EDT Bausch Health trading resumes

13:06 EDT North American rail traffic down 0.1% for the week ending July 20 - The Association of American Railroads or AAR reported U.S. rail traffic for the week ending July 20. For this week, total U.S. weekly rail traffic was 480,083 carloads and intermodal units, up 1.4% compared with the same week last year. Total carloads for the week ending July 20 were 214,348 carloads, down 3.4% compared with the same week in 2023, while U.S. weekly intermodal volume was 265,735 containers and trailers, up 5.8% compared to 2023. Five of the 10 carload commodity groups posted an increase compared with the same week in 2023. They included grain, up 2,387 carloads, to 17,300; petroleum and petroleum products, up 1,591 carloads, to 10,745; and farm products excl. grain, and food, up 1,413 carloads, to 16,880. Commodity groups that posted decreases compared with the same week in 2023 included coal, down 6,278 carloads, to 57,906; nonmetallic minerals, down 3,825 carloads, to 30,758; and motor vehicles and parts, down 2,175 carloads, to 12,466...North American rail volume for the week ending July 20 , on 10 reporting U.S., Canadian and Mexican railroads totaled 317,607 carloads, down 4.1% compared with the same week last year, and 346,231 intermodal units, up 3.9% compared with last year. Total combined weekly rail traffic in North America was 663,838 carloads and intermodal units, down 0.1%. North American rail volume for the first 29 weeks of 2024 was 19,112,113 carloads and intermodal units, up 2.3% compared with 2023. Publicly traded companies in the space include CSX (CSX), Canadian National (CNI), Canadian Pacific Kansas City (CP), Norfolk Southern (NSC), Union Pacific (UNP) Rail Vision (RVSN), Wabtec (WAB), Trinity Industries (TRN), FreightCar America (RAIL) and Greenbrier (GBX). Reference Link

12:39 EDT Fenbo Holdings Ltd trading resumes

12:21 EDT Bausch Health trading halted, news pending

12:01 EDT Lamb Weston falls -26.2% - Lamb Weston is down -26.2%, or -$20.61 to $58.02.

12:01 EDT Group 1 Automotive rises 8.9% - Group 1 Automotive is up 8.9%, or $27.02 to $331.78.

12:00 EDT Nabors Industries rises 9.4% - Nabors Industries is up 9.4%, or $7.65 to $88.65.

11:53 EDT Chijet Motor Co Inc trading resumes

11:47 EDT Kering: 2H24 recurring operating income could be down 30% vs. 2H23

11:32 EDT Home BancShares raises quarterly cash dividend 1.5c to 19.5c per share - Home BancShares, parent company of Centennial Bank, announced that its board of directors has declared a regular 19.5c per share quarterly cash dividend payable September 4 to shareholders of record August 14. This cash dividend represents a 1.5c per share, or 8.3%, increase over the 18c cash dividend paid during the second quarter of 2024.

11:19 EDT Disneyland workers union committee reaches tentative contract agreement - In a series of Wednesday tweets, union coalition Disney Workers Rising Bargaining Committee said, "Breaking Alert: Tentative Agreement Reached on our Disney Contracts. We have fought hard for the past four months and this tentative agreement would not have been possible without the strength we showed this past week with our rally and Unfair Labor Practice vote. We achieved our goals - a 3-year contract that contains significant wage increases for all cast members, seniority increases and additional premiums as well as the retention of premiums. We also addressed issues that will make the attendance policy work better for cast members. With personal actions like wearing our union button and signing a petition to massive 1,000-person rallies and worldwide news coverage, we have shown Disney that we are the true magic makers of the park. We stood up to the company's unfair labor practices and showed them that we were willing to do whatever it took to get the contract we deserved. Our solidarity and victory today sends a message to workers everywhere - when we fight, we win." Reference Link

11:03 EDT QXO Inc trading resumes

10:58 EDT QXO Inc trading halted, volatility trading pause

10:22 EDT Bausch Health trading resumes

10:16 EDT Bausch Health trading halted, volatility trading pause

10:04 EDT Sophia Genetics expands relationship with OncoHelix - SOPHiA GENETICS announced that OncoHelix will implement MSK-ACCESS powered with SOPHiA DDM. The organization, which currently uses the SOPHiA DDM Platform for myeloid testing, will use the new liquid biopsy solution to advance its oncology testing capabilities. OncoHelix will be live on MSK-ACCESS powered with SOPHiA DDM later this summer.

10:01 EDT Group 1 Automotive rises 9.0% - Group 1 Automotive is up 9.0%, or $27.41 to $332.17.

10:01 EDT Prog Holdings rises 20.8% - Prog Holdings is up 20.8%, or $7.22 to $41.85.

10:00 EDT Sage Therapeutics sinks 20% to $10.49 after essential tremor study fails

10:00 EDT SFL Corporation falls -13.2% - SFL Corporation is down -13.2%, or -$1.84 to $12.11.

09:48 EDT Wabash falls -11.3% - Wabash is down -11.3%, or -$2.55 to $20.00.

09:47 EDT Lamb Weston falls -18.5% - Lamb Weston is down -18.5%, or -$14.58 to $64.04.

09:47 EDT Schneider National rises 7.2% - Schneider National is up 7.2%, or $1.75 to $26.20.

09:46 EDT General Dynamics says supply chain 'improved, but not completely healed'

09:42 EDT Regencell Bioscience Holdings Ltd trading resumes

09:39 EDT Pieris Pharmaceuticals trading resumes

09:34 EDT Pieris Pharmaceuticals trading halted, volatility trading pause

09:31 EDT Grom's Top Draw Animation secures over $1M in new assignments - Top Draw Animation has secured additional, previously unreported assignments totaling over $1M. The new projects, which follow its May, 2024 commencement of assignments valued at over $2.9M, was confirmed by Cyrus Mistry, COO of Top Draw Animation.

09:28 EDT Maris-Tech launches Uranus-based Diamond System solution - Maris-Tech announced the launch of the Uranus-based Diamond System, a 360 degrees 3D situational awareness solution specifically designed for Armored Fighting Vehicles. This advanced product aims to set a high standard in defense technology and operational excellence, looking to redefine the next generation of situational awareness edge computing solutions, and bring unparalleled performance and operational efficiency to the defense sector. The Diamond System leverages advanced AI technologies to provide comprehensive 360 degrees 3D situational awareness and early threat detection capabilities. It integrates high definition day and night cameras, ultra-high-definition displays, and flexible camera interfaces, ensuring full surround and 3D coverage. This solution is engineered to address the challenges of urban and open terrain combat, enhancing crew protection and operational effectiveness.

09:26 EDT AMC Entertainment trading halted, news pending

09:21 EDT Ferrari to extend cryptocurrency payments to European dealers - Ferrari announced that it will extend its cryptocurrency payment system to its network of European dealers from the end of July. The entry into the European market follows the successful launch of this alternative payment system in the United States less than a year ago, to support dealers in better addressing the evolving needs of its clients. By the end of 2024, Ferrari will expand cryptocurrency transactions to other countries in its international dealer network, where cryptocurrencies are legally accepted. Reference Link

09:18 EDT Silynxcom receives additional order from Israel Defense Forces - Silynxcom has received an additional order from the Israel Defense Forces for its advanced tactical communication headset devices. This latest order for $315,000 comes after a $500,000 order from the IDF was announced by the Company on July 9, 2024. The Company also recently announced on July 9, 2024, a strong performance for the first half of 2024 on a preliminary unaudited basis, including estimated revenue for the six months ended June 30, 2024 of approximately $5.31 million - highlighting accelerated operational and business growth - and cash and cash equivalents and marketable securities of approximately $3.69 million as of June 30, 2024.

09:14 EDT T-Mobile to invest $4.9B in Metronet joint venture with KKR - T-Mobile (TMUS) announced it has entered into a definitive agreement to establish a joint venture, or JV, with KKR (KKR) that will acquire Metronet including its broadband infrastructure, residential fiber business operations and existing customers. As part of the transaction, the JV will also acquire Oak Hill Capital's existing stake. Oak Hill Capital will re-invest to retain a minority position and founder John Cinelli will also retain a minority position once the deal closes. The company currently reaches more than 2M homes and businesses across 17 states with fiber solutions built on a broadband platform. Following the transaction's close, Metronet will become a wholesale services provider for its retail customers and 100% of its residential fiber retail operations and customers will transition to T-Mobile. T-Mobile will have full responsibility for residential customer acquisition and support, leveraging its differentiated retail, marketing, brand and service model, and will utilize Metronet's digital and fiber infrastructure expertise to expand to more households with fiber broadband services. Metronet will focus on build plans, network engineering and design, network deployment, and customer installation. Following the transaction close, Metronet is expected to be self-funding on a go forward basis and it is expected to reach 6.5M homes passed by the end of 2030. To support this business plan T-Mobile does not expect to make any additional capital contributions to the JV. KKR is making the investment in Metronet through its global infrastructure strategy. The transaction is expected to close in 2025, subject to customary closing conditions and regulatory approvals. At closing, T-Mobile is expected to invest approximately $4.9B to acquire a 50% equity stake in the JV and 100% of Metronet's residential fiber retail operations and customers, as well as funding of the JV.

09:11 EDT Atlassian appoints Adobe's Chief Strategy Officer Scott Belsky to board - Atlassian (TEAM) announced it is appointing Scott Belsky to its Board of Directors effective August 1 . Scott is the Chief Strategy Officer and Executive Vice President, Design & Emerging Products, at Adobe (ADBE), a firm in creative, digital document and digital experience technology. "I'm excited for Scott to bring his deep strategy and product experience to our Board. He's built loveable products used by millions of people around the world, and knows how to deliver customer value. Scott understands the tech industry and has a strong pulse for the trends shaping our world. Never has that been more important, as Atlassian takes on the opportunity in the AI-era," said Mike Cannon-Brookes, co-Founder and co-CEO, Atlassian.

09:07 EDT Trex Company launches new Trex Signature X-Series Railing - Trex Company has expanded its popular Trex Signature Railing line with the introduction of X-Series Cable Rail and X-Series Frameless Glass Rail. Now available through Trex channel partners, these two new offerings blend modern profiles with simplified installation to deliver a winning combination for contractors and clients.

09:06 EDT Silvaco provides update on Ole Christian Andersen litigation - Silvaco Group announced an update to the pending litigation regarding Silvaco, Inc. v. Ole Christian Andersen et al relating to the acquisition of Nangate Denmark in 2018 which pre-dates the current management team. The case was tried in the Superior Court of the State of California, and a jury verdict was delivered on July 23, 2024. After deliberations, the jury awarded Nangate $11.3 million in damages under the breach of contract claims. This amount does not include potential statutory prejudgment interest in an estimated amount of up to $4.2 million. Further, punitive damages relating to the claims of fraud will be considered at a hearing expected to be held on August 16, 2024. Punitive damages, if any, would be payable by the Company only to the extent they are above the amount awarded in connection with the breach of contract claims. While the Company respects the jury's decision and intends to abide by any final rulings or judgments, it is also exploring all options, including the possibility of post-trial motions and appeals. As of June 30th, 2024, Silvaco had an unaudited cash, cash equivalents and marketable securities position of $102.3 million.

09:05 EDT Taboola announces Taboola for Audience - Taboola announced Taboola for Audience, a new AI-powered technology that empowers publishers to drive significantly more traffic, which is more critical now than ever. Taboola for Audience allows publishers to future-proof their audience development goals and navigate substantial changes affecting their referral traffic from search and social media. In 2024 alone, publishers have contended with changes to search engine and social media traffic, as well as ongoing uncertainty around the impact of Generative AI advancements.

09:03 EDT Fluence Energy expands Digital Services Center with RMDC in India - Fluence Energy announced its Digital Services Center has expanded with a new Remote Monitoring and Diagnostics Center in India. The RMDC is co-located with Fluence's Global Innovation Center in Bengaluru and will bring together experts from across the business to drive innovative customer solutions. Fluence's DSC is expected to serve as a central hub for applying operational data intelligence to the global fleet of assets managed by Fluence's team across 47 markets and will provide insights for the company's research and development, and services functions. These efforts ultimately are anticipated to help provide more value to customers by optimizing their assets' performance.

09:02 EDT CPC Pain & Wellness issues letter to fellow XWELL shareholders - CPC Pain & Wellness, a significant XWELL shareholder that beneficially owns 394,200 or 9.42% of XWELL's outstanding shares, issued the below letter to its fellow shareholders. The letter informs shareholders of CPC's recent lawsuit filing against the incumbent members of XWELL's Board of Directors for breach of their fiduciary duties and for the Board's wrongful and inequitable efforts to prevent CPC from nominating a competing slate of directors and consequently denying shareholders the opportunity to choose who they elect to XWELL's Board at the upcoming annual shareholder meeting. In its letter, CPC details how current Board members have personally benefited from XWELL while overseeing an astounding decline in XWELL shareholder value and substantial net losses. CPC also shares in the letter its vision for restoring and maximizing shareholder value.

09:01 EDT RTX's Pratt & Whitney GTF engines surpass 950 orders and commitments in 2024 - RTX's Pratt & Whitney business announced more than 950 GTF engine orders and commitments since the beginning of 2024. In total, more than 11,000 GTF engine orders and commitments have been placed by more than 90 customers worldwide.

08:56 EDT LPL Financial: Investment Advisors joins broker-dealer, RIA, custodial platforms - LPL Financial announced that the advisors of Investment Advisors Financial Group have joined LPL Financial's broker-dealer, RIA and custodial platforms. The team reported having served approximately $1 billion in advisory, brokerage and retirement plan assets and joins LPL from Osaic. Founded in 1979 by Thomas E. Musumeci and headquartered in Eatontown, N.J., Investment Advisors Financial Group includes a diverse mix of advisors with backgrounds in accounting, finance, tax and investments who work together to address each client's unique wealth management needs. The group, which is led by Musumeci, James Flannery and Annie Silvestro - Musumeci's daughter - consists of 22 advisors and eight associates and administrative staff.

08:52 EDT AT&T sees 2H24 cash taxes $1B higher vs. 2H last year

08:50 EDT AT&T: 95%+ of long-term debt is fixed

08:49 EDT AT&T on track for $21B-$22B of capital investment in 2024 - Sees higher capital expenditures and lower vendor financing payments versus 2023. Comments taken from Q2 earnings conference call.

08:43 EDT Glatfelter, Berry announce new brand name in connection with HHNF merger - Berry Global Group (BERY) and Glatfelter Corporation (GLT) announced that the proposed merger of Berry's Health, Hygiene and Specialties Global Nonwovens and Films business with Glatfelter progressed further today with the creation of the Magnera brand. The launch of this new identity marks the next chapter in the transaction journey, emphasizing a commitment to innovation and leadership in the specialty materials industry. Magnera will leverage a broad platform of 46 global manufacturing facilities, offering its customers innovative solutions more quickly from closer locations and minimizing environmental impact.

08:40 EDT ServiceNow acquires Raytion to enhance GenAI-powered capabilities, no terms - ServiceNow announced it has acquired Raytion to enhance GenAI-powered search and knowledge management capabilities on the Now Platform. Raytion's industry-leading information retrieval technology will enable unified real-time access to business-critical data across multiple enterprise sources for a more powerful, efficient, and personalized AI search experience, all on a single technology platform. The complexity of modern enterprise environments will drive the need for more intelligence about the data, so that organizations can take control of highly distributed, diverse, and dynamic information1. With Raytion technology combined with ServiceNow AI Search, users can find the answers they require without having to know exactly where the information is located. Raytion's technology will integrate secure access to information from enterprise data sources and allow ServiceNow's AI Search to provide users with an industry-leading, intelligent search experience and the information they need, all from a single entry point. This includes data within ServiceNow and from third-party systems. ..Since 2001, Germany-based Raytion has been implementing and operating large-scale business solutions for Global 500 companies and organizations worldwide. For ServiceNow, this announcement follows previous acquisitions of Enable OH&S technology, Hitch Works, and 4Facility technology as part of the company's ongoing commitment to drive AI transformation on a global scale, enhance employee experiences, and power the future of work. ServiceNow completed the acquisition of Raytion in July 2024. Financial terms of the deal were not disclosed.

08:39 EDT Blade Air Mobility opens shareholder Q&A platform ahead of Q2 results - Blade Air Mobility announced the opening of the shareholder Q&A platform to be used for its upcoming conference call to discuss the financial results for the second quarter ended June 30, 2024. Blade will conduct the call at 4:30pm ET on Wednesday, August 7, 2024. Starting today, any shareholder will be able to submit and upvote questions to management of the Company.

08:38 EDT Safe & Green engages firm for sales-leaseback on Waldron facility - Safe & Green Holdings has engaged Northmarq Capital to secure a suitable deal and partner for a sale-leaseback involving its Waldron facility located in Durant, Oklahoma. This strategic move for the property appraised at $4.7 million is intended to free up working capital, thereby supporting Safe & Green Holdings' growing customer demand and facilitating its aggressive expansion strategies.

08:37 EDT PainReform files patent covering manufacturing process for PRF-110 - PainReform announced it has filed a patent covering its new and highly scalable manufacturing process for PRF-110, its flagship product designed to revolutionize post-operative pain control. The patent filing follows successful completion and testing of the new process. This milestone not only marks a critical step forward in preparation for future potential market launch of PRF-110, allowing a smooth step-wise increase of batch manufacturing, but also underscores the Company's commitment to enhancing manufacturing efficiency and reducing costs.

08:36 EDT Scorpius set to launch first mammalian cGMP campaign at San Antonio facility - Scorpius Holdings announced that the Company expects to launch its first cGMP mammalian manufacturing campaign at its San Antonio manufacturing facility in the 3rd quarter of 2024. This milestone highlights the expansion of the Company's biomanufacturing capabilities, particularly in the field of mammalian cell culture production for advanced biopharmaceuticals. Scorpius has previously initiated cGMP activities in its microbial facilities, and the commencement of mammalian cGMP campaigns marks a significant development as it opens additional revenue streams for the Company's CDMO operations. Scorpius boasts a dedicated mammalian cell culture facility with cGMP-compliant controlled cleanrooms illustrating Scorpius' commitment to providing tailored and adaptable manufacturing solutions.

08:35 EDT Mullen Automotive announces GAMA purchases 29 Mullen GOs - Mullen Automotive announces GAMA, one of Mullen international distributors, has placed an order for 29 Mullen GOs, the Company's commercial micro urban delivery vehicle. The order is valued at $304,000 USD with shipment to GAMA planned for early August 2024. GAMA was recently announced as one of Mullen's European distribution partners for southeastern Europe covering the Balkans Region, which includes Bosnia and Herzegovina, Serbia, Montenegro, Croatia, Slovenia, Macedonia, Albania, Greece and Bulgaria. GAMA represents Mullen's full commercial electric vehicle product line.

08:33 EDT 180 Degree Capital notes accident involving CEO Kevin Rendino - The company said, "180 Degree Capital announced that its CEO and Co-Portfolio Manager, Kevin Rendino, was involved in an accident and is currently receiving treatment for his injuries. His doctors have informed us that he is responding well to treatments and his current recovery prognosis is positive. Our thoughts are with him and his family. We will provide updates as more information becomes available. 180 Degree Capital also affirms that its business operations remain in full force and are continuing as usual under the management of Daniel B. Wolfe, 180 Degree Capital's President and Co-Portfolio Manager."

08:33 EDT Nature's Miracle receives record grow light sales order of $2.4M - Nature's Miracle has received a $2.4M purchase order of Efinity LED grow lights from a top indoor grower based in California. The payment for the order will begin by October 1 with a delivery date in late November. The $2.4M illion sales order will increase the company's Q4 revenue by the same amount.

08:30 EDT Encompass Health increases share repurchase authorization - Encompass Health approved resetting the aggregate common stock repurchase authorization to $500M. The company repurchased approximately $17M of its common stock during Q2 and had approximately $181M remaining under the prior authorization as of June 30.

08:24 EDT Netlist secures order finalizing $303M damages award against Samsung - Netlist, Inc. (NLST) announced the denial of Samsung's (SSNLF) post-trial motions in the case of Netlist v. Samsung Electronics in the United States District Court for the Eastern District of Texas. The Court's Memorandum Opinion and Order, denying post-trial motions, combined with the Final Judgment, entered in August 2023 bring this case to a close in the District Court. The Court has upheld the jury's verdict and damages award in the April 2023 trial and confirmed that Samsung willfully infringed Netlist's patented technologies and that none of the asserted claims are invalid. Netlist's patents in the April trial cover both high bandwidth memory or HBM and DDR5 memory that are foundational to generative artificial intelligence computing. The $303,150,000 award was granted as a reasonable royalty for Samsung's infringement of Netlist's patents for a limited past damages period.

08:21 EDT VERSES AI announces approval of spatial web standards - VERSES AI announces that the Institute of Electrical and Electronics Engineers Standards Association P2874 working group voting members have approved the Spatial Web standards: Hyperspace Modeling Language and Hyperspace Transaction Protocol. "We are honored that the IEEE working group members have approved HSML and HSTP as the global standards for AI, IoT and robotic interoperability and governance. The approval positions these new standards to potentially become as ubiquitous as HTTP, WiFi, or Bluetooth protocols that enable interoperability between billions of devices and systems," said Gabriel Rene, CEO of VERSES. "Industry and governments want to safely drive the proliferation of AI and autonomous technologies and we believe that the Spatial Web standards pave the road for both safer and faster market adoption."

08:20 EDT Spectral AI announces total U.S, international portfolio has 26 granted patents - Spectral AI announced a 30% increase in its patent portfolio that strengthens and protects its proprietary, AI-driven DeepView System wound assessment platform. Total patents granted to the Company increased to 26 through July 8, 2024 from 20 at December 31, 2023, consisting of 12 U.S. and 14 international patents. These patents cover various aspects of the Company's DeepView System platform. The Company continues to protect its data and processes with an additional 38 pending patent applications worldwide, consisting of seven pending U.S. patents and 31 pending international patents. The patents encompass nine distinct patent families.

08:19 EDT Annovis Bio secures U.S. patent for treatment of acute TBI with buntanetap - Annovis Bio announced the issuance of a U.S. patent for methods of treating acute traumatic brain injuries, TBI, with its lead drug candidate, buntanetap. "We are thrilled to achieve this significant milestone for buntanetap," said Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis. "Nerve cell death is a common underlying factor in many brain conditions, beyond just Alzheimer's and Parkinson's. Our preclinical studies in TBI and stroke animal models have demonstrated buntanetap's efficacy in preventing cell death and loss of function, and it is our duty to explore its potential benefits for victims of brain trauma, a prevalent issue in the U.S."

08:17 EDT Mobiquity Technologies expands partnership with AdFuel - Mobiquity Technologies announces the expansion of its strategic partnership with Adfuel Inc. This collaboration aims to enhance the digital presence of local businesses by leveraging Adfuel's expertise in digital marketing and Mobiquity's advanced data solutions and technology.

08:15 EDT Catalyst Pharmaceuticals enters exclusive agreement with Kye Pharmaceuticals - Catalyst Pharmaceuticals announced that it has entered into a License, Supply, and Commercialization Agreement with Kye Pharmaceuticals granting Kye the exclusive Canadian commercial rights to AGAMREE, a novel corticosteroid for the treatment of Duchenne Muscular Dystrophy, DMD, and potentially other indications. Under the terms of the agreement, Catalyst will supply the product to Kye, which will assume full responsibility for obtaining regulatory approval for AGAMREE for the treatment of DMD from Health Canada and all future aspects of commercialization of the product within Canada. Kye currently markets FIRDAPSE, Catalyst's flagship product for the treatment of Lambert Eaton myasthenic syndrome, in Canada.

08:13 EDT Soluna closes $30M funding from Spring Lane Capital for Project Dorothy 2 - Soluna Holdings announced it has closed its latest round of financing from Spring Lane Capital for a 48 MW expansion of Soluna's flagship behind-the-meter data center, Project Dorothy, facility. SLC, a private equity firm providing hybrid project capital for sustainability solutions, has agreed to lead the financing round of $30 million. propels our mission to scale our operational assets under management. Project Dorothy, our premier Bitcoin Hosting site, will double in size through this partnership with SLC. We look forward to working with the industry's top Bitcoin miners to deliver sustainable hosting and best in class services." ..."We are excited about Soluna's continued momentum over the last two years and, in particular, Project Dorothy 2's progress. The expansion comes at a time when solutions for the Texas electricity grid are gravely needed while simultaneously we are at an inflection point with AI and its effect on climate," said Robert Day, Co-founding Partner at Spring Lane Capital. "We believe the success of Soluna's model reflects the first truly positive solution when it comes to AI, computing and climate and we are proud to continue to support their breakthrough developments in the green data center sector."

08:11 EDT Duos Technologies Group secures $2.2M funding for EDC production - Duos Technologies Group has secured sufficient funding for the production of its first three EDCs. Duos Edge AI entered into secured promissory notes for a total of $2.2 million with two institutional investors in the Company. The funding will be used for the construction, deployment and initial operations of EDCs in remote districts, including for schools, government, and health facilities. The first EDC is expected to be in full production by late October, with the second and third units following closely and expected to be in production by November. As disclosed in a recent 8-K, the deal is for $2.2 million in debt, maturing at the end of 2025. The notes carry an interest charge of 10% per annum and there are no payments in the interim. Duos Edge AI will reserve funds from revenues generated on these units for repayment purposes and the Company will hold any receipts from its ATM facility to ensure that notes are repaid on time. Duos will continue to support operations for Duos Edge AI and is currently reviewing potential ongoing debt funding proposals from other lenders as the subsidiary continues to expand.

08:11 EDT Intermex welcomes two new senior leaders to its team - International Money Express (IMXI) announces the addition of two new senior leaders to its team. These strategic hires underscore Intermex's commitment to growth, innovation, and exceptional service in the remittance industry. Intermex announces that Chris Kawula has joined the Company as the new Executive Vice President, Head of Sales. Chris brings extensive leadership experience, most notably from his role as Senior Vice President, Sales and Account Management at Western Union (WU). Intermex also welcomes Cheyenne Moore as the new Director of Inside Sales.

08:09 EDT CenterWell plans to open 23 senior primary care centers at certain Walmarts - CenterWell, the health care services business of Humana (HUM) announced plans to lease clinical space and open senior-focused primary care centers at 23 Walmart (WMT) Supercenter retail stores in Florida, Georgia, Missouri and Texas. The centers will operate under the CenterWell Senior Primary Care and Conviva Care Centers brand names and will provide seniors in these communities with greater access to primary care services designed specifically for older adults. The new centers will be conveniently located next to Walmart stores in clinical office space that was formerly occupied by Walmart Health. CenterWell expects the centers to be equipped, staffed and opened no later than the first half of 2025. Financial terms of the agreement were not disclosed. "CenterWell is committed to providing seniors with high quality health care that is accessible, comprehensive, and most of all, personalized. We are excited by the unique opportunity to lease space from a world-class community partner such as Walmart and offer seniors in these four states greater access to our integrated approach to care," said Sanjay Shetty, M.D., president of CenterWell. "These nearly two dozen primary care centers are specifically designed for seniors, and each location's design, including dedicated entrances and easy parking, offers patients the access that they have come to expect at our clinics across the nation. We are eager to expand on our mission to help patients lead happier, healthier lives."

08:08 EDT LuxUrban Hotels provides update on its go to market revenue strategies - LuxUrban Hotels provided the following update. In early June 2024, LuxUrban changed its "go to market revenue management strategies" which is producing favorable results. The points presented reflect these favorable results on a same store sales basis. 2024 Q3 RevPAR Projections showing 3% year over year growth based on an 11% ADR lift; 2024 Q4 RevPAR Projections showing 15% year over year growth based on a 17% ADR lift. Rob Arigo, CEO of LuxUrban, stated, "The new revenue management team is just scratching the surface of the potential growth for our hotels."

08:07 EDT Ultragenyx to present GTX-102 Angelman syndrome program update - Ultragenyx Pharmaceutical will share the latest clinical data, regulatory progress and program next steps for GTX-102, its investigational antisense oligonucleotide for Angelman syndrome, on Wednesday, July 24, at the 2024 Angelman Syndrome Foundation Family Conference and Research Symposium in Sandusky, Ohio. The ASF data presentation will review the previously disclosed Phase 1/2 results presented at AAN and an update on plans to initiate a Phase 3 pivotal trial by the end of the year.

08:06 EDT Fly-E Group to launch three new electric motorcycle models - Fly-E Group announced the upcoming launch of three new electric motorcycle models. These models, the DP, EK PRO, and DT, are scheduled for official unveiling and launch in New York at the end of October 2024. Zhou Ou, Chairman and Chief Executive Officer of Fly-E, remarked, "We are incredibly excited to unveil our three new products. These are not just motorcycles; they represent lifestyle choices for modern users wanting to express their personality. Our team is dedicated to innovation, investing substantial time and resources into their design and R&D. Our goal is to create high-performance electric motorcycles with distinctive designs and premium features."

08:05 EDT Amphenol increases quarterly dividend 50% to 16.5c per share - Amphenol's board of directors approved a 50% increase in the company's quarterly dividend, from 11c per share to 16.5c per share. The new dividend amount will be paid on October 9 to shareholders of record as of September 17.

08:04 EDT Daxor awarded $550K matching-fund extension from U.S. DHA - Daxor Corporation announces that Daxor has received a $550K matching-fund extension from the U.S. Defense Health Agency to its Phase II SBIR contract. This additional funding will support adding hematocrit measurement to a future generation blood volume analyzer. The upgrade eliminates the need for hematocrit testing from third-party devices to perform the BVA test.

08:04 EDT Boeing provides digital flight operations solution for Ryanair - Boeing (BA) and Ryanair (RYAAY) are elevating efficiency across Ryanair's fleet of primarily 737s with the addition of Boeing's Jeppesen FliteDeck Pro 5.0 electronic flight bag solution. This strategic multi-year agreement, providing support for the carrier's Next-Generation 737 and 737 MAX fleet, underscores Ryanair's dedication to continuous improvement and innovation in airline operations. FliteDeck Pro will provide Ryanair with tailored route information and the latest technology, including Smart Airport Maps to optimize taxi routes, reduce fuel consumption and improve ground safety. As a platform-agnostic EFB solution, FliteDeck Pro provides airport moving maps, customer-inserted content and tailored maps.

08:03 EDT Genius Group appoints Riaz Shah to board of directors - Genius Group announced the appointment of global learning leader Mr. Riaz Shah, OBE to its Board of Directors. Mr. Shah is Professor of Practice for Innovation & Leadership at Hult International Business School, where he leads sessions with senior executives, focusing on global megatrends, digital disruption and innovation.

08:02 EDT RTX's Pratt & Whitney GTF engines to power 11 Airbus A220 for Air Niugini - Pratt & Whitney, an RTX (RTX) business, and Air Niugini have finalized engine and aftermarket agreements for the GTF engines that will power the airline's fleet of 11 Airbus (EADSY) A220 aircraft. Pratt & Whitney will provide a full suite of support services with a 12-year EngineWise Comprehensive agreement. With this order, Air Niugini becomes a first-time GTF customer.

07:56 EDT Virpax Pharmaceuticals regains compliance with Nasdaqminimum bid price - Virpax announced that it has received formal notice from the Listing Qualifications staff of The Nasdaq Stock Market indicating that Virpax has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).

07:55 EDT Blackstone Mortgage reduces dividend to 47c from 62c per share - Katie Keenan, Chief Executive Officer, said, "We believe stockholder return is well served by balancing current return with optimization of book value and long-term earnings potential through our strategic capital allocation decisions. We assess the dividend with the Board each quarter, prudently considering a variety of factors, and our Board has declared a third quarter dividend of 47c per share, which we believe reflects a sustainable level relative to long-term earnings power. With strong liquidity, accelerating repayments, and an emerging investment pipeline, BXMT is well positioned to deploy capital accretively in this environment and continue its forward trajectory through the cycle."In addition, BXMT declared a dividend of 47c per share of class A common stock with respect to the third quarter of 2024. This dividend is payable on October 15, to stockholders of record as of September 30.

07:46 EDT Jacobs awarded contract from FBI - Jacobs was awarded the competitive Federal Bureau of Investigation Information Technology Supplies and Support Services 2nd Generation Blanket Purchase Agreement. This agreement, which will also be available to the broader Department of Justice, provides critical IT support to the FBI. The contract highlights Jacobs' nearly two-decade-long collaboration with the FBI, emphasizing its role as a reliable provider of innovative IT solutions. The FBI expects the ITSSS-2, its primary agreement for essential IT services over the next eight years, to come with an $8B total ceiling contract value and flexible options. This agreement underscores Jacobs' dedication to bolstering the FBI's mission-critical operations. Under the multiple-award, indefinite-delivery/indefinite-quantity contract, Jacobs will deliver crucial IT solutions in seven key areas: workplace services, business applications, delivery services, platform services, infrastructure services, emerging technologies and other IT services.

07:34 EDT Beacon Biosignals announces strategic collaboration with Skye Bioscience - Beacon Biosignals announced a strategic collaboration with Skye Bioscience to enhance its upcoming CBEYOND Phase 2 clinical trial of Nimacimab. This partnership will incorporate sleep quality and sleep apnea endpoints via the Beacon Platform and the FDA 510(k)-cleared Dreem 3S EEG device to better understand the comprehensive impact of Nimacimab on patients with obesity. "We are thrilled to collaborate with Skye Bioscience to bring our expertise in sleep monitoring and analysis to this important clinical trial," said Jacob Donoghue, MD, PhD, CEO of Beacon Biosignals. "Our FDA-cleared Dreem 3S EEG headband and AI-powered analytics platform will enable the collection of clinically-validated sleep assessments from patients in their own homes. This will provide valuable insights into how Nimacimab may improve sleep quality and reduce sleep apnea, conditions often comorbid with obesity and cardiometabolic disease."

07:34 EDT SupremeX to cease production at Niagra Falls facility, close Concord facility - Supremex announced optimization initiative aimed at improving costs, overall efficiency, productivity and achieving synergies within its Envelope segment operations. These initiatives are expected to result in annual cost savings in excess of $2M once all measures are implemented, primarily from the reduction of rent and other fixed costs, and modest productivity improvements. First, the Company is ceasing production at its very small facility in Niagara Falls, New York, effective immediately and maintaining the premises as a distribution centre. Additionally, Supremex will close its facility in Concord, Ontario, as its lease expires in February 2025 and will transfer the location's most efficient production equipment, primarily to its other Greater Toronto area envelope plants in Mississauga and Etobicoke over the coming months. These measures will not result in significant headcount reduction as the vast majority of employees will be relocated within the Company's existing operations. Related to these moves, Supremex will record restructuring charges of approximately $2.7M before taxes for a period extending from the third quarter of 2024 through the first quarter of 2025.

07:33 EDT Notable Labs receives FDA clearance to proceed further with volasertib study - Notable Labs announced progress for the Phase 2 volasertib program following receipt of "Clearance to Proceed" from the FDA and agreement on the dosing plan for its Phase 2 clinical trial. With trial start-up activities launched in the first quarter of this year, Notable intends to initiate enrollment in the Phase 2 study for PMP-enabled development of volasertib for relapsed refractory acute myeloid leukemia, AML, in the coming months. The Phase 2 study will begin with a dose optimization lead-in and incorporate body-surface area (BSA) dosing, prophylactic antibiotic treatment and best supportive care. The second part of the study is planned to enroll patients with R/R AML who are PMP-predicted responders. The Company is working towards initiating dosing of the first subjects in the Phase 2 trial. Based on our plan, Notable expects to have initial data from the dose optimization lead-in during the fourth quarter of 2024, initiate selective enrollment of PMP-predicted responders after that, and start to report initial efficacy results during H1 2025.

07:25 EDT Iris Energy increases Childress power capacity from 600 MW to 750 MW - IREN announce it has secured an additional 150MW of immediately available power capacity at its Childress site. This increase follows the approval of network studies by ERCOT and execution of an amended connection agreement with AEP. This increases the Company's total secured grid-connected power capacity to 2,310MW. 2024: 910MW immediately available power; 510MW of data centers planned in 2024; 910MW of data centers planned in 2025. 2026: 1,400MW West Texas site on schedule; Data center planning underway. 2027-2030: greater than1GW of additional development pipeline.

07:20 EDT Sila Realty Trust reports final results from 'Dutch Auction' tender offer - Sila Realty Trust announced the final results of its modified "Dutch Auction" tender offer to purchase for cash up to $50M in value of shares of the company's common stock, which expired at 5:00 p.m., New York City time, on July 19, 2024. Based on the final count by Computershare Trust Company, N.A., the depositary and paying agent for the Offer, 4,670,381 shares of common stock were validly tendered at the final purchase price of $22.60 per share and not properly withdrawn. In accordance with the terms and conditions of the Offer, and based on the final count by the Depositary, the company has accepted for purchase 2,212,389 shares of common stock at a purchase price of $22.60 per share, for an aggregate cost of approximately $50M, excluding fees and expenses relating to the Offer. The number of shares of common stock that the company has accepted to purchase in the Offer represents approximately 3.9% of the total number of shares of common stock outstanding as of July 19, 2024. Following payment for the shares of common stock purchased in the Offer, the Company had approximately 55M shares of common stock outstanding.

07:18 EDT Vintage Wine Estates files for bankruptcy - Vintage Wine Estates filed a voluntary petition for reorganization under chapter 11 of title 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware. Over the preceding months, the company experienced negative financial headwinds that severely impacted its liquidity position. The debtors have filed a motion seeking approval of the marketing auction and sale of the company's assets. The company, as borrower, intends to enter into a debtor-in-possession financing facility pursuant to which the lenders will make available to the company a credit facility in the amount of $60.5M. The DIP Facility will be used to support the company's business during the restructuring process. The Chapter 11 filing constitutes an event of default that accelerated the company's obligations under the Loan and Security Agreement with BMO Bank. As of the petition date, the company had an aggregate of approximately $310M in outstanding loans and commitments. The company expects commercial operations to continue largely business-as-usual. The company also announced its intention to voluntarily delist its common stock and warrants from Nasdaq and deregister its common stock and warrants. The company has notified Nasdaq of its intent to voluntarily delist its common stock and warrants, and intends to file a notice on Form 25 relating to such delisting with the SEC on or about August 5. The company expects the delisting of the common stock and warrants to be effective on or about August 15 and intends to file a Certification and Notice of Termination of Registration with the SEC on or about August 15. Following delisting, the common stock and warrants may be eligible to be quoted on the Pink Open Market operated by the OTC Markets Group. The company is currently evaluating multiple preliminary indications of interest with respect to the potential sale of various of its assets. The company also completed the sale of Cosentino Winery's real property and equipment for cash proceeds of $10.5M that were used to pay down debt.

07:16 EDT BranchOut Food announces $3.925M CEO-led investment - BranchOut Food announced the closing of a $525,000 investment in company led by its CEO, Eric Healy, who invested $400,000, with Eagle Vision Fund LP investing $100,000, and the Company's President investing $25,000, in exchange for the issuance of 692,529 shares of common stock . In addition, the Company closed a convertible note for $3,400,000 with Kaufman Kapital. Complete details of these transactions can be found in the Company's Current Report on 8-K filed with the Securities and Exchange Commission. The capital will be used to complete the build out of the Company's large-scale production facility in Peru, including for its 3rd and 4th Radiant Energy Vacuum machines built by EnWave Corporation (NWVCF). The Company expects the new factory to be online starting in Q4 and to have approximately $40M in production capacity and estimated margins of 40-50%. BranchOut Food is currently filling orders valued at over $8M from some of the country's largest retailers but has turned down additional orders in the trailing twelve months as it awaits the new factory opening.

07:15 EDT Gritstone to host KOL event to discuss GRANITE cancer vaccine program - Gritstone bio will host a virtual key opinion leader event on Friday, August 2 at 9:00 AM ET featuring J. Randolph Hecht, MD, and Howard Brown who will discuss the unmet need and current treatment landscape for patients with metastatic microsatellite stable colorectal cancer. Gritstone management will also highlight the development of Gritstone's personalized neoantigen vaccine program, GRANITE, as a potential treatment for immunologically "cold" tumors including MSS-CRC. Mature progression-free survival data from a randomized Phase 2 study of GRANITE in frontline MSS-CRC are expected in the third quarter of 2024.

07:13 EDT OTC Markets announces real-time data distribution with uSMART collaboration - OTC Markets Group announced new data distribution capabilities in collaboration with uSMART Securities. uSMART Securities is now a distributor for OTC Markets Group's L1 and L2 real-time data and with the data being available in their mobile app for participating users. uSMART operates a financial trading platform that provides real-time stock quotes, stock trading strategies for investors, and 24-hour account service.

07:12 EDT Blackstone Mortgage announces $150M share repurchase program - BXMT also announced that its Board of Directors has authorized a share repurchase program for up to $150M of the Company's class A common stock

07:11 EDT Blackstone Mortgage declares Q3 dividend of 47c per share - Katie Keenan, Chief Executive Officer, said, "We believe stockholder return is well served by balancing current return with optimization of book value and long-term earnings potential through our strategic capital allocation decisions. We assess the dividend with the Board each quarter, prudently considering a variety of factors, and our Board has declared a third quarter dividend of 47c per share, which we believe reflects a sustainable level relative to long-term earnings power. With strong liquidity, accelerating repayments, and an emerging investment pipeline, BXMT is well positioned to deploy capital accretively in this environment and continue its forward trajectory through the cycle."

07:09 EDT Sylogist provides update on normal course issuer bid - Sylogist announced that Paradigm Capital lnc. will replace BMO Nesbitt Burns as its broker under its ongoing normal course issuer bid effective today. On November 17, 2023, the Company announced that the Toronto Stock Exchange had accepted its Notice of Intention to make a Normal Course Issuer Bid in place effective November 21, 2023. The NCIB will continue on its existing terms and will terminate on the earlier of: November 20, 2024; or when permitted purchases thereunder are completed. Sylogist may otherwise elect to terminate the NCIB at any time.

07:02 EDT General Dynamics reports company-wide backlog of $91.3B - The consolidated book-to-bill ratio, defined as orders divided by revenue, was 0.8-to-1 for the quarter. Company-wide backlog was $91.3 billion. Estimated potential contract value, representing management's estimate of additional value in unfunded indefinite delivery, indefinite quantity (IDIQ) contracts and unexercised options, was $38.5 billion. Total estimated contract value, the sum of all backlog components, was $129.8 billion.

06:50 EDT Pfizer's hemophilia A gene therapy candidate shows positive Phase 3 results - Pfizer announced positive topline results from the Phase 3 AFFINE study evaluating giroctocogene fitelparvovec, an investigational gene therapy for the treatment of adults with moderately severe to severe hemophilia A. The study achieved its primary objective of non-inferiority, as well as superiority, of total annualized bleeding rate from Week 12 through at least 15 months of follow up post-infusion compared with routine Factor VIII replacement prophylaxis treatment. Following a single 3e13 vg/kg dose, giroctocogene fitelparvovec demonstrated a statistically significant reduction in mean total ABR compared to the pre-infusion period. Key secondary endpoints as defined by the trial protocol were met and also demonstrated superiority compared to prophylaxis. Giroctocogene fitelparvovec was generally well tolerated. Serious adverse events were reported in 15 patients - 20% -, including 13 events reported by 10 patients assessed as related to treatment. Treatment-related adverse events generally resolved in response to clinical management. Analyses of the full Phase 3 dataset from the AFFINE study are ongoing and additional data will be presented at upcoming medical meetings. Giroctocogene fitelparvovec has been granted Fast Track and Regenerative Medicine Advanced Therapy designations from the FDA, as well as Orphan Drug designations in the U.S. and the EU. Pfizer will discuss these data with regulatory authorities in the coming months.

06:38 EDT Clean Energy breaks ground at Texas RNG production facility - Clean Energy has broken ground on a renewable natural gas - RNG - production facility at South Fork Dairy in Dimmitt, TX. Home to a 16,000-cow herd, the facility will produce RNG, an ultra-clean transportation fuel that is made from organic waste and receives a negative carbon-intensity score. The construction of the digesters and processing plant is forecasted to cost approximately $85M and is expected to be completed in 2025. The South Fork Dairy facility is set to be one of the biggest RNG production developments in the country with an anticipated 2.6 million gallons of RNG to be produced annually once completed. All the RNG fuel produced at the site will make its way into Clean Energy's nationwide network of stations. Agriculture accounts for nearly 10% of U.S. greenhouse gas emissions. RNG is a transportation fuel made entirely from organic waste and drastically reduces GHG emissions by an average of 300% versus diesel.

06:35 EDT Dorian LPG declares irregular cash dividend of $1.00 per share - Dorian LPG has declared an irregular cash dividend of $1.00 per share of the company's common stock. The dividend is payable on or about August 21 to all shareholders of record as of the close of business on August 8.

06:27 EDT Taylor Morrison sees FY24 home closings 12,600-12,800 - Sees FY24 average closing price $600,000-$610,000. Sees FY24 effective tax rate 25%.

06:15 EDT Deutsche Bank sees 2024 provision for credit losses slightly above 30 bps - The company said, "For the first six months, provision for credit losses was EUR 915M, compared to EUR 772M in the prior year period. Corporate Bank provisions were up 9% year on year at EUR 198M, while Private Bank provisions were down 11% to EUR 367M, benefitting from the sale of non-performing loans and the non-recurrence of provisions relating to a small number of idiosyncratic events in the prior year period. Investment Bank provisions were EUR 313M, materially higher than the prior year period, and largely affected by the commercial real estate sector. The bank now expects the full-year 2024 provision for credit losses to be slightly above 30 basis points, above prior guidance. This reflects commercial real estate provisions which are moderately lower, although improving at a slower-than-expected pace, as well as improvements in the Corporate Bank."

06:09 EDT Allarity urges shareholders to vote for reverse stock split, decrease in shares - Allarity issued a statement encouraging its stockholders to participate actively in the upcoming annual meeting of stockholders scheduled on July 26. The Board has put a proposal before stockholders for a reverse stock split. Allarity has requested approval of the reverse stock split to regain and sustain compliance with Nasdaq requirements. The Board stated that if the reverse stock split is not approved by stockholders, the company's common stock may be delisted from Nasdaq and could complicate stockholder's ability to trade the company's common stock, impact its stock price and affect stockholder's ability to buy or sell when desired. The Board emphasized the importance of this stockholders' vote, a positive vote for the reverse stock split as well as the decrease in authorized shares.

06:05 EDT Organigram makes third tranche $1M investment into Phylos - Organigram has completed an early partial funding of its final third tranche investment into Phylos Bioscience, a U.S. cannabis genetics company and provider of production ready seeds, with the remaining portion of the final tranche to be funded upon completion of the newly expanded final milestone. As part of the expanded milestone, Phylos is required to deliver 21 unique auto-flower seed varietals for testing and phenotyping by Organigram no later than September 30, followed by a second cohort of 21 auto flower seed varietals to be delivered no later than January 31, 2025. In addition to the auto-flower seeds, Organigram received an expanded genetics licence from Phylos that, in addition to THCV, includes access to high potency CBG, CBC and CBDV seed based cultivars. Organigram has exclusive rights in Canada until May 2028 to commercialize THCV derived from Phylos' cultivars.

05:31 EDT Collins Aerospace relocates Singapore manufacturing facility to new site - Collins Aerospace, an RTX business, announced the relocation of its Singapore manufacturing facility to a new site in Seletar Aerospace Park, Singapore. This move represents a significant investment of $250M. Scheduled to begin construction in the fourth quarter of 2025, the new facility is expected to be completed by 2027. This strategic relocation will enable Collins to transfer its operations from the current Bedok site to the new Seletar Aerospace Park location, approximately 15 miles away. Production is anticipated to commence in 2028, with dual production capability maintained at the Bedok facility over a multi-year transition plan.

05:20 EDT GE Aerospace announces EVA Air order for GEnx engines - GE Aerospace (GE) announced that following EVA Air's recent deal to purchase four Boeing (BA) 787-10 Dreamliner aircraft, the airline has placed an order for GEnx engines to power their new aircraft.

05:09 EDT Gilead announces results from PURPOSE 1 trial - Gilead announced full efficacy and safety results from its pivotal, Phase 3 PURPOSE 1 trial. Detailed data from the trial's interim analysis announced in June showed that lenacapavir, the company's twice-yearly injectable HIV-1 capsid inhibitor, demonstrated zero infections, 100% efficacy and superiority to background HIV incidence for the investigational use of HIV prevention in cisgender women. Lenacapavir also demonstrated superior prevention of HIV infections when compared with once-daily oral Truvada. The new data provide details on the efficacy, safety and tolerability of twice-yearly lenacapavir injections; drug adherence among trial participants, including poor levels of adherence to daily oral pre-exposure prophylaxis, or PrEP, and high levels of adherence to lenacapavir; and demographic and behavioral characteristics of trial participants, including pregnant women and adolescents. The data are being presented at a special late-breaking session at the 25th International AIDS Conference in Munich, Germany and were published in The New England Journal of Medicine. Overall, lenacapavir was highly effective among trial participants, with zero HIV infections observed in the lenacapavir group compared to background HIV incidence, translating to a 100% reduction in HIV infections. Additionally, compared to once-daily Truvada, lenacapavir reduced HIV incidence by 100%, a result that was statistically superior. Per trial protocol, because PURPOSE 1 met its key efficacy endpoints of superiority of twice-yearly lenacapavir to bHIV and once-daily oral Truvada at interim analysis, the independent Data Monitoring Committee recommended that Gilead stop the blinded phase of the trial and offer open-label lenacapavir to all participants. As of July 23, more than 840 trial participants have already opted to switch to lenacapavir. PURPOSE 1 is evaluating the safety and efficacy of twice-yearly, subcutaneous lenacapavir for PrEP and once-daily oral Descovy for the investigational use of HIV prevention in cisgender women. Data from the Phase 3, double-blind, active-controlled, multicenter, randomized trial were collected from 5,345 HIV-negative, cisgender adolescent girls and young women aged 16-26 at 25 sites in South Africa and three sites in Uganda. Lenacapavir and Descovy were tested in parallel for HIV prevention, with one group receiving twice-yearly injectable lenacapavir and one group taking once-daily oral Descovy. Additionally, a third group was assigned once-daily oral Truvada. Baseline demographics and characteristics were balanced across all groups. Trial participants were randomized in a 2:2:1 ratio to lenacapavir, Descovy and Truvada, respectively. Because effective PrEP options already exist, there is broad consensus in the PrEP field that a placebo group would be unethical; thus, the trial used bHIV as the primary comparator and Truvada as a secondary comparator. Most of the participants reported prior HIV testing. A small minority reported no prior use of PrEP. Adherence to lenacapavir and to placebo injections included in the oral PrEP study groups was high: 91.5% of all trial participants received on-time injections at week 26, and 92.8% of participants received on-time injections at one year. On-time injection rates were similar across all study groups, whether receiving lenacapavir or placebo injections. Sixteen incident HIV cases among 1,068 women were observed in the Truvada group and 39 incident HIV cases among 2,136 women were observed in the Descovy group. HIV incidence with Descovy was not different from bHIV in the primary efficacy analysis and no evidence of difference was observed compared to Truvada in the secondary efficacy analysis. Adherence to once-daily oral Descovy and Truvada, measured through detection of tenofovir diphosphate in blood samples from a subset of patients, was low and declined over time. These adherence levels are consistent with prior reports of low adherence of daily oral PrEP among cohorts of cisgender women, especially among younger women, across geographies. HIV protection was strongly associated with adherence to Descovy in the case-control analysis. Most participants with incident HIV infection had low or no detection of tenofovir diphosphate. Within the Descovy group, those with medium or high adherence had significantly lower odds of acquiring HIV infection compared to those with low adherence. In the Descovy group, at 26 weeks, 30.2% of trial participants had high or medium adherence to the drug, and 69.8% had low adherence. At one year in the Descovy group, 15.9% of trial participants had high or medium adherence, and 84.1% had low adherence. In the Truvada group, at 26 weeks, 10.9% of trial participants had high or medium adherence, and 89.1% had low adherence. At one year in the Truvada group, 7.0% of trial participants had high or medium adherence and 93.0% had low adherence. There were no new safety concerns identified, and lenacapavir, Descovy and Truvada were generally well tolerated. For lenacapavir and Descovy, aside from injection site reactions, the most common adverse events observed were headache, urinary tract infection, genitourinary chlamydia infection and nausea. Serious AEs were reported in 2.8% of participants in the lenacapavir group, compared to 4% in the Descovy group and 3.3% in the Truvada group. Frequency of AEs was similar across study groups. A total of 25,329 injections were administered: 10,154 in 2,138 participants assigned to the lenacapavir group, and 15,175 in 3,206 participants receiving placebo injections in the Descovy and Truvada groups. ISRs related to the study drug or injection procedures were the most common AEs observed, and there were no serious ISRs among participants receiving lenacapavir or placebo injections. Lenacapavir is injected into the subcutaneous layer of fat in the abdomen to form a drug depot, which will get smaller and resolve, or reduce in size substantially, prior to the next lenacapavir injection. The drug depot may be palpable as a bump or nodule but is usually not visible. About 64% of women in the lenacapavir group experienced nodules compared to 16.6% who received placebo injections. ISR incidence, including nodules, decreased with subsequent injections. Four women in the lenacapavir group discontinued study drug due to ISRs, compared to zero women who discontinued due to ISRs on placebo. As a result of strong community input from advocates in South Africa and Uganda, PURPOSE 1 is the first HIV prevention trial to intentionally include pregnant and lactating women. There were 510 pregnancies among 487 participants: 193 among women in the lenacapavir group, with zero HIV infections; 219 among women in the Descovy group, with four HIV infections; and 98 among women in the Truvada group, with one HIV infection. At the time of interim analysis, 54.3% of pregnancies were completed and 45.7% were ongoing. Available pregnancy outcomes were similar to those expected for the population. Community advocates also stressed the importance of including adolescents and young people in PURPOSE 1. The median age of all trial participants was 21 years, and 124 participants were under 18 years. Gilead expects results in late 2024/early 2025 from the program's other pivotal trial, PURPOSE 2, which is assessing twice-yearly lenacapavir for PrEP among cisgender men, transgender men, transgender women and gender non-binary individuals in Argentina, Brazil, Mexico, Peru, South Africa, Thailand and the United States who have sex with partners assigned male at birth. The regulatory filing for lenacapavir for PrEP will include the results of both PURPOSE 1 and PURPOSE 2, if positive, to ensure lenacapavir for PrEP can be approved for multiple populations and communities most in need of additional HIV prevention options.